Gilead’s Covid-19 Remdesivir Drug Scores FDA Approval; Shares Surge
Russophrenia... Or How A Collapsing Country Runs The World
A Tale of 2 Automotive Stocks to Buy
COVID-19 Records Shattered Across Europe As France Tops 40k New Cases: Live Updates
Central Europe Reports Record Jump In COVID-19 Cases; US Hospitalizations Hit 2-Month High: Live Updates
American Airlines Posts $2.4B Quarterly Loss; Street Sees 22% Downside
Futures Slide Ahead Of Final Debate, On Lack Of "Stimulus Optimism"
Blain: The Market Has No Memory
AstraZeneca Covid-19 Brazil Trial To Continue After Volunteer Dies - Report
Spain Becomes Sixth Country To Top 1 Million COVID-19 Cases: Live Updates
US Open – Markets awaiting breakthrough
BD’s Covid-19-Flu Combo Test Wins European Clearance
Opko Health Rolls Out Multiplex COVID-19, Influenza A/B Test
Peak Optimism? S&P Futures Hit After Too Much "Stimulus Optimism" Sends 10Y Yields Surging
Chinese City Launches Emergency COVID-19 Vaccine Program; India Outbreak Continues To Slow: Live Updates
A no-deal Brexit could damage the UK's ability to cope with pandemics
Xeris Wins FDA Fast Track Path For Epilepsy Treatment; Shares Spike 9%
First Tests Of New "Immunity Passports" Will Take Place Wednesday
US Open – Deal making time
The Beginning Of The End Of Sovereignty? Europe Launches First "Socially-Targeted Bonds"
Futures Rebound On Stimulus Optimism Ahead Of "Do Or Die" Deadline
Macro Briefing: 20 October 2020
Kamada To Supply Plasma-Based Covid-19 Therapy To Israel; Shares Surge 6%
Global Health Bureaucrats Want Even More Power to Impose Their Plans Across National Borders
Food waste: cities can make the difference
AstraZeneca Gets EU Recommendations For Heart Failure, Lung Treatments
United Airlines Adds 8 New Routes To Boost Latin America Presence
Futures Jump Ahead Of Tuesday Stimulus Deadline
Daily market commentary: The countdown clock is running down quickly with both Brexit and the US election
Schlumberger Sinks 9% On Dismal 3Q Revenue